Phosphorylated tau (p-tau) is pathologically linked to Alzheimer's disease (AD), chronic traumatic encephalopathy (CTE), and other NDs associated with TBI and has recently emerged as a promising, potentially sensitive biomarker of acute mTBI (3, 6). The gene discussed is MAPT; the disease is Alzheimer disease.